Twenty years ago, it was not uncommon for individual academic researchers to conduct their own clinical research studies, but this has diminished today as the complexity of these studies has increased due to compliance with all the laws, guidelines and regulations. Good Clinical Practice (GCP) must be followed, and it is not always easy to cope with all this work. This has lead to an increase in the cooperation between academia, pharma and CROs. In recent years, this has increased in particular in oncology and haematology, both nationally and internationally. Read more about the past and future of clinical drug development from Bengt Gustavsson, Senior advisor at SCRO.
